SCPX NightHawk Biosciences Company Projected Revenue

Graphic logo of Scorpius Holdings Inc. (SCPX)

Line downtime risks and operational losses at Scorpius Holdings, Inc. (SCPX) are creating pressure, as clearly demonstrated by the company's projected sales chart. The value 0.01 represents the current level of this metric. Business revenues are based on CDMO services and the creation of cell lines; meanwhile, the need for working capital to scale production is temporarily constraining free cash flow growth.

SCPX - Scorpius Holdings, Inc. Company Future Sales Volume over the range 02/21/2024 - 04/26/2025

Financial and market metric breakdowns for Scorpius Holdings, Inc (SCPX)

- stock value and consensus price forecast:
Fundamental company valuation:Scorpius Holdings Inc.
Signature product of NightHawk Biosciences

This indicator is based on forecasting models of future cash inflows from the sale of goods and services. A decline in its values necessitates an analysis to determine whether this is a temporary correction or a sign of a systemic crisis. For Scorpius Holdings, Inc. (SCPX), this trend reflects the demand for CDMO services for the production of biologics and vaccines. It is critical for investors to correlate this data with capacity utilization in the US. By analyzing the trend of the firm's sales performance, one can identify hidden opportunities for asset undervaluation.